BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Jeff Collins to serve as a judge for the 2nd Carolina Entrepreneurial Initiative Challenge
News | 04. 22. 2006
